SL-25.1188 is a monoamine oxidase B (MAO-B) inhibitor potentially for treatment of Alzheimer's dementia and smoking cessation. SL-25.1188 is characterized in vivo by reversible binding, high brain uptake, and very slow plasma metabolism. References: Saba W, Valette H, Peyronneau MA, Bramoullé Y, Coulon C, Curet O, George P, Dollé F, Bottlaender M. [(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse. 2010 Jan;64(1):61-9. doi: 10.1002/syn.20703. PubMed PMID: 19728365.

纯度：≥98%

CAS：185835-97-6